Dopamine agonists and Othello's syndrome

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

Background: Othello's syndrome (OS) is a delusion of infidelity. We describe seven cases of OS in Parkinson's disease (iPD) patients using dopamine agonists. Methods: We searched the Mayo Clinic Medical Records System to identify all patients with OS. Clinical data abstracted include sex, age of onset of iPD, age of onset of OS, medications, effect of discontinuing the dopamine agonist, neuroimaging, and comorbidities. Results: Seven non-demented iPD patients with dopamine agonist implementation time locked to the development and resolution of OS are reported. The average age of iPD onset was 46.6 years (Standard deviation: 5.0 years), and OS onset was 53.7 years (7.1 years). All seven patients had significant marital conflict as a result of the delusions. Conclusions: OS can be associated with dopamine agonist use and can lead to serious consequences. Dopamine agonist cessation eliminates the delusion of infidelity and should be the first treatment option.

Original languageEnglish (US)
Pages (from-to)680-682
Number of pages3
JournalParkinsonism and Related Disorders
Volume16
Issue number10
DOIs
StatePublished - Dec 1 2010

Keywords

  • Delusion
  • Dopamine
  • Othello's syndrome
  • Parkinson's disease

ASJC Scopus subject areas

  • Neurology
  • Geriatrics and Gerontology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Dopamine agonists and Othello's syndrome'. Together they form a unique fingerprint.

  • Cite this